Q3 2022 Holdings
Filed 2022-11-14 | 80 holdings | $411.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $35.7K | 1,741,840 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $38.8K | 16,149,179 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $43.1K | 1,312,443 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $43.2K | 1,798,085 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $43.2K | 5,590,048 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $43.8K | 3,203,783 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $49.2K | 3,294,859 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $51.3K | 8,813,021 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $64.2K | 3,255,588 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $64.7K | 3,611,494 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $66.4K | 3,501,814 | 0.0% |
| Merus N V | COM | N5749R100 | $69.0K | 3,444,420 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $76.9K | 2,078,220 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $97.1K | 4,339,521 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $100.6K | 8,291,988 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $102.2K | 4,692,604 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $107.8K | 9,275,158 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $127.1K | 2,872,953 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $173.1K | 21,751,284 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.1M | 1,370,947 | 0.3% |
| Calithera Biosciences Inc(CALA) | COM NEW | 13089P507 | $1.4M | 464,742 | 0.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.6M | 6,595,801 | 2.3% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $12.4M | 879,085 | 3.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $23.4M | 3,780,694 | 5.7% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $28.1M | 1,616,665 | 6.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $31.1M | 2,084,824 | 7.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $62.6M | 3,976,543 | 15.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $71.1M | 2,717,020 | 17.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $72.3M | 3,678,947 | 17.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $96.3M | 7,509,059 | 23.4% |